Safety and Efficacy of Asciminib in Pediatrics and Young Adults With Relapse/Refractory (r/r) Philadelphia Positive (Ph+) or ABL-class Ph-like Acute Lymphoblastic Leukemia (ALL)
IsraelRecruitingPHASE1, PHASE2
Conditions
Acute Lymphoblastic Leukemia · Leukemia, Lymphoblastic, Acute, Philadelphia-Positive · Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Novartis Investigative Site, Ramat Gan, Israel
Study leads
Novartis Pharmaceuticals
Study Director
Novartis Pharmaceuticals